• 中文 | CN

Resources

Pave an Expressway to Phase I – Strategies that Accelerate Your Early Phase Programs

The success of any new drug development starts in its early phase. The probability of success of a molecule increases dramatically after it passes first-in-human (FIH) and proof-of-concept (POC) studies. Building a comprehensive understanding of the molecule is crucial to successful early phase development. API salt form and formulation selections are also key factors to successful phase I studies. Effective CMC strategies can significantly enhance the speed of early phase development and ultimately the chance for success in late-stage development. This webinar will present our experience in using the integrated API and drug product platform and formulation technologies to accelerate early-phase development to phase I and beyond.
Access on-demand webinars & videos

In this webinar, we will discuss the importance of phase-appropriate process development and various

Scroll to Top

Brochure & Flyers Registration

Please enable JavaScript in your browser to complete this form.
Checkboxes

Webinar Registration

Please enable JavaScript in your browser to complete this form.
Checkboxes
Please enable JavaScript in your browser to complete this form.
Checkboxes